Cash flow has outrun profit
Free cash flow over the trailing twelve months grew 205.6% year over year, well ahead of net income’s 94.8% increase over the same period. Operating cash flow over the same period rose 223.9%. Capital expenditure, at $565.5 million TTM, grew 336.7% and now absorbs 10.7% of revenue.
Gross margin stands at 26.8%.
Readers wanting the mechanics should check the quarter’s MD&A disclosures directly; it is one of the questions these filings, on their own, cannot answer.
The base case uses a stage-one growth assumption of 2.00%. These are model values under stated assumptions, not a comparison with the share price.
Operating cash flow grew 223.9%, alongside capital-expenditure growth of 336.7%. Diluted share count fell 0.74% over the period; the supplied data do not identify what drove the gap between net income and free cash flow.
What to watch next
The supplied facts do not identify the company’s most recent quarterly filing or its filing schedule. A future annual report could show whether the free cash flow margin holds near its current percentile or reverts.